Résultats de la recherche - 482 results
Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.
Treatment Outcome Vaccine Efficacy Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen Manuscript versions: DOI: ...
Estimating the direct Disability-Adjusted Life Years associated with SARS-CoV-2 (COVID-19) in the Republic of Ireland: The first full year
contributed to 98.5% of the DALY s. Of total symptomatic cases, 6.5% required hospitalisation and of those hospitalised 10.8% required intensive care unit treatment. COVID-19 was likely to be the second highest ...
Invasive pulmonary aspergillosis in solid-organ transplant patients in the intensive care unit.
for Research and Treatment of Cancer/Mycosis Study Group and Research Consortium criteria), and eight as Aspergillus-colonization. Among patients with IPA, 20 (45.5%) developed IPA during their ICU stay ...
Occurrence of (suspected) genotoxic flavoring substances in Belgian alcohol-free beers.
rather originated from heat-treatments or from plant-based extracts. Health Topics: Food consumption and food safety Consommation et sécurité alimentaires Voedselconsumptie en –veiligheid Service: ...
EU health information progress: the harvest of policy supporting projects and networks
effects of specific medical treatments, interventions and diagnostics; cohort studies; or studies focusing on research methods. We searched bibliographic databases and EU project databases for policy ...
The non-fatal burden of cancer in Belgium, 2004–2019: a nationwide registry-based study
increased disability due to surgical treatment. Results The age-standardized non-fatal burden of cancer increased from 2004 to 2019 by 6 and 3% respectively for incidence- and prevalence-based YLD s. In 2019, ...
Healthcare-associated infections and antimicrobial use in Belgian nursing homes: results of three point prevalence surveys between 2010 and 2016
treatment of an infection: 66.4% in HALT-1, 60.9% in HALT-2 and 64.1% in HALT-3. Uroprophylaxis accounted for 28.7%, 35.6% and 28.4% of all prescriptions, respectively. Conclusions None withstanding the ...
Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016–2020)
Lyme borreliosis Persisting non-specific symptoms Post-treatment Lyme disease syndrome Abstract: Background Patients with Lyme borreliosis (LB) may report persisting non-specific symptoms such as ...
Lyme borreliosis in Belgium: a cost-of-illness analysis
erythema migrans (EM) or disseminated/late LB, including patients who developed post-treatment Lyme disease syndrome (PTLDS). Direct medical, direct non-medical (transportation & paid help) and indirect ...
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future
Publication Type: Peer reviewed scientific article Authors: T. Geukens; M. Brandão; A. Laenen; J. Collignon; C. Van Marcke; I. Louviaux; W. Demey; S. Van Wambeke; D. Schrijvers; S. Lecomte; J. Mebis; A. Rutten; C. Fontaine; W. Lybaert; S. Aspeslagh; J.-C. ...